Quarterly ResultMay 6, 2026, 05:27 PM
ICAHN ENTERPRISES Q1 LP Unit Loss $(0.71); Net Sales $2.31B
AI Summary
Icahn Enterprises reported a net loss attributable to the company of $(459)M for Q1 2026, an increase from $(422)M in Q1 2025, though basic and diluted loss per LP unit improved to $(0.71) from $(0.79). Net sales rose to $2,311M from $2,002M year-over-year, and net cash provided by operating activities significantly improved to $397M from a $(182)M use. The company's total equity decreased to $2,347M, and the fair value of its Investment Funds declined to $2.2B. Strategic moves included the completion of Viskase's merger with Enzon Pharmaceuticals, Inc., and an increased ownership stake in CVR Energy to approximately 71%.
Key Highlights
- Net loss attributable to Icahn Enterprises was $(459)M, compared to $(422)M in Q1 2025.
- Basic and diluted loss per LP unit improved to $(0.71) from $(0.79) year-over-year.
- Net sales increased to $2,311M for Q1 2026, up from $2,002M in Q1 2025.
- Net cash provided by operating activities significantly improved to $397M from $(182)M.
- Total equity decreased to $2,347M as of March 31, 2026, from $3,426M at year-end 2025.
- Fair value of Investment Funds decreased to $2.2B from $2.7B.
- Viskase completed its merger with Enzon Pharmaceuticals, Inc.; Icahn Enterprises now owns ~94%.
- Increased ownership in CVR Energy to ~71% by acquiring 783,404 shares for $16M.
Price Impact
More from IEP